Enanta Pharmaceuticals Stock Forecast - Simple Moving Average

ENTA Stock  USD 8.60  0.23  2.60%   
The Simple Moving Average forecasted value of Enanta Pharmaceuticals on the next trading day is expected to be 8.71 with a mean absolute deviation of 0.32 and the sum of the absolute errors of 19.16. Enanta Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Enanta Pharmaceuticals stock prices and determine the direction of Enanta Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Enanta Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
As of November 29, 2024, Payables Turnover is expected to decline to 0.40. In addition to that, Receivables Turnover is expected to decline to 9.67. As of November 29, 2024, Common Stock Shares Outstanding is expected to decline to about 18.4 M. The current year's Net Loss is expected to grow to about (104.1 M).
A two period moving average forecast for Enanta Pharmaceuticals is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

Enanta Pharmaceuticals Simple Moving Average Price Forecast For the 30th of November

Given 90 days horizon, the Simple Moving Average forecasted value of Enanta Pharmaceuticals on the next trading day is expected to be 8.71 with a mean absolute deviation of 0.32, mean absolute percentage error of 0.14, and the sum of the absolute errors of 19.16.
Please note that although there have been many attempts to predict Enanta Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Enanta Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Enanta Pharmaceuticals Stock Forecast Pattern

Backtest Enanta PharmaceuticalsEnanta Pharmaceuticals Price PredictionBuy or Sell Advice 

Enanta Pharmaceuticals Forecasted Value

In the context of forecasting Enanta Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Enanta Pharmaceuticals' downside and upside margins for the forecasting period are 6.05 and 11.38, respectively. We have considered Enanta Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
8.60
8.71
Expected Value
11.38
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Enanta Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Enanta Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria112.4914
BiasArithmetic mean of the errors 0.0743
MADMean absolute deviation0.3248
MAPEMean absolute percentage error0.0298
SAESum of the absolute errors19.165
The simple moving average model is conceptually a linear regression of the current value of Enanta Pharmaceuticals price series against current and previous (unobserved) value of Enanta Pharmaceuticals. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for Enanta Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Enanta Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enanta Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
5.958.6111.27
Details
Intrinsic
Valuation
LowRealHigh
7.9513.8216.49
Details
8 Analysts
Consensus
LowTargetHigh
25.3827.8930.96
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.37-1.23-1.16
Details

Other Forecasting Options for Enanta Pharmaceuticals

For every potential investor in Enanta, whether a beginner or expert, Enanta Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Enanta Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Enanta. Basic forecasting techniques help filter out the noise by identifying Enanta Pharmaceuticals' price trends.

Enanta Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Enanta Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Enanta Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Enanta Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Enanta Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Enanta Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Enanta Pharmaceuticals' current price.

Enanta Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Enanta Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enanta Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Enanta Pharmaceuticals stock market strength indicators, traders can identify Enanta Pharmaceuticals entry and exit signals to maximize returns.

Enanta Pharmaceuticals Risk Indicators

The analysis of Enanta Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Enanta Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting enanta stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Enanta Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enanta Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enanta Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enanta Pharmaceuticals Stock:
Check out Historical Fundamental Analysis of Enanta Pharmaceuticals to cross-verify your projections.
For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enanta Pharmaceuticals. If investors know Enanta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enanta Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.66)
Earnings Share
(5.48)
Revenue Per Share
3.407
Quarterly Revenue Growth
(0.05)
Return On Assets
(0.17)
The market value of Enanta Pharmaceuticals is measured differently than its book value, which is the value of Enanta that is recorded on the company's balance sheet. Investors also form their own opinion of Enanta Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Enanta Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enanta Pharmaceuticals' market value can be influenced by many factors that don't directly affect Enanta Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enanta Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enanta Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enanta Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.